| Emerging
Stock Report: Advanced Viral Research has been added to our "stocks
to watch" list Apr 22, 2004 (M2 PRESSWIRE via COMTEX) -- The Emerging Stock Report, has added Advanced Viral Research Corp (OTCBB: ADVR) to our stock to watch list this morning. We are going to be keeping a very close eye on the company as they seem to be moving in the upward direction with what seems to be very little to activate this move. The technicals on this company are pretty good as it seems their market has purged a bit as of late. We are going to be keeping this on the top of our radars to see if there are any developments in the near future. |
| StockGate:
New Short Selling Scandal Via Berlin Stock Exchange? Apr 26, 2004 (financialwire.net via COMTEX) -- (FinancialWire) Naked short-selling opponents are claiming that "the Berlin Stock Exchange" has listed upwards of 30% of the approximately 100 companies listed by FinancialWire as having been potential targets of naked short-selling in the U.S., apparently without their permission or authorization. U.S. companies supposedly were no longer under the spell of manipulative trading due to changes in regulations some three weeks ago requiring U.S. brokers, such as A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), to refuse orders from Canadian and other brokers without a sure-fire "affirmative determination." Short-selling opponents allege that forged documents may have been used at the Berlin Stock Exchange to list the companies to make them more vulnerable to a continuation of manipulative trading, and that many have had to hire private investigators because the U.S. Securities and Exchange Commission would not investigate or intervene. Financial consultant C. Austin "Bud" Burrell, who has investigated the manipulative abuses and is a close follower of the ongoing controversy, notes that a listing on a foreign exchange qualifies the company's stock for "arbitrage," which Burrell notes is "one of the two specific exemptions from the Short Sale Rule created by the 1993 Administrative Ruling rendered to Broker Dealers, the other being legitimate Market Maker activities." Burrell says that in some instances, "companies have found markets being made in their stock in markets like Berlin, without ever having applied for such a listing. In some cases, the manipulators have actually forged submitted false listing applications supported by the target companies US SEC reports, without their knowledge or consent." Recently, renowned columnist, Jack Anderson, who writes the "Washington Merry-Go-Round," alleged that much of the naked short selling in small cap stocks drains small U.S. companies of their market caps and their small investors of their nest-eggs specifically to funnel money into terrorist hands, a sort of double-whammy against the American capitalist system. "The USA Patriot Act, adopted in October 2001, expanded the scope of U.S. money-laundering rules in order to make it harder for terrorists to move money without attracting attention. It includes beefed-up know-your-customer requirements for some financial institutions, according to some legal experts" said the U.S. financial newspaper. Recently, leading market makers and brokers named in various lawsuits and other actions, including FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion's (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), were given a "reprieve" were forced to comply with new short-selling market regulations imposed by the NASD after the SEC had "sat on" the NASD request to plug material loopholes for almost 2-1/2 years. "The new rules expand the scope of the affirmative determination requirements to include orders received from broker/dealers that are not members of NASD ("non-member broker/dealers"). The new rule is on the web at www.nasdr.com/2610_2004.asp#04-03 The rule itself, while welcomed by small companies and their shareholders in the U.S., nevertheless raised an outcry because the NASD's request to put it into effect had set on a shelf at the SEC since 2001. Recent wrist slaps have involved Falcon Research, Inc., fined $10,000, SG Cowen Securities Corporation, fined $230,000, and Sterne, Agee & Leach, Inc., fined $35,000. Meanwhile, CBS Marketwatch, a venture between Marketwatch (NASDAQ: MKTW) and Viacom's (NYSE: V) CBS unit, has suggested that victims of securities fraud may be able to file for theft claims on tax returns instead of capital losses. The scandal has embroiled hundreds of companies and dozens of brokers and marketmakers, in a web of internaitional intrigue, manipulative short-selling and cross-border accusations and denials. Comments on Regulation SHO ended January 5, and may be viewed at www.sec.gov/rules/proposed/s72303.shtml . Some 122 companies, including 13 brokers, such as FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion's (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), have been embroiled for over a year in a raging controversy The remaining 109 companies among the 122 named to date have issued press releases or been named in the media as having been victimized, or as taking various actions, either alone or in concert with other companies, to oppose manipulative trading in the form of illegal naked short selling. The actions have ranged from lawsuits to withdrawals and threatened withdrawals from the electronic trading system managed by the Depository Trust & Clearing Corp., to withdrawals from toxic financings, to the issuance of dividends or name changes designed to squeeze manipulators, to joining associations or networks or to contacting regulatory authorities to provide documentation of abuses or otherwise complain. The complete list of those 108 companies include Advanced Viral Research Corp. (OTCBB: ADVR), AdZone Research, Inc. (OTCBB: ADZR), Amazon Natural Treasures (OTC: ANTD), America's Senior Financial Services (OTCBB: AMSE), American Ammunition, Inc. (OTCBB: AAMI), AngelCiti Entertainment (OTCBB: AGLC), ATSI Communications, Inc. (OTC: ATSC), Federal Agricultural Mortgage / Farmer Mac (NYSE: AGM) Allied Capital (NYSE: ALD), American Motorcycle (OTC: AMCYV), American International Industries (OTCBB: AMIN), Ameri-Dream (OTC: AMDR), Adirondack Pure Springs Mt. Water Co. (OTCBB: APSW), ATSI Communications, Inc. (OTC: ATSC) Bluebook International (OTCBB: BBIC), Blue Industries (OTCBB: BLIIV), Bentley Communications (OTCBB: BTLY), BIFS Technologies Corporation (OTCBB: BIFT), Biocurex (OTCBB: BOCX). Broadleaf Capital Partners, Inc. (OTCBB: BDLF), Chattem, Inc. (NASDAQ: CHTT), Critical Home Care (OTCBB: CCLH), Composite Holdings (OTC: COHIA), CyberDigital, Inc. (OTCBB: CYBD). Diamond International Group (OTCBB: DMND), Dobson Communications Corp. (NASDAQ: DCEL), Eagle Tech Communications (OTC: EATC), Edgetech Services (OTCBB: EDGH); Also, Endovasc Ltd. (OTCBB: EVSC), Enviro-Energy Corporation (OTCBB: ENGY), Environmental Products & Technologies (OTC: EPTC), Environmental Solutions Worldwide, Inc. (OTCBB: ESWW), EPIXTAR Corp. (OTCBB: EPXR), eResearchTechnologies, Inc. (NASDAQ: ERES), Flight Safety Technologies (OTCBB: FLST), Freddie Mac (NYSE: FRE), FreeStar Technologies (OTCBB: FSRCE), Front Porch Digital, Inc. (OTCBB: FPDI), Geotec Thermal Generators, Inc. (OTCBB: GETC), Genesis Intermedia (OTC: GENI), GeneMax Corp. (OTCBB: GMXX), Global Explorations Inc (OTC: GXXL), Global Path (OTCBB: GBPI), GloTech Industries, Inc. (OTCBB: GTHI), Green Dolphin Systems (OTCBB: GLDS), Group Management (OTCBB: GPMT), Hop-On (OTC: HPON), H-Quotient, Inc., (OTCBB: HQNT), Hyperdynamics Corp. (OTCBB: HYPD), International Biochem (OTCBB: IBCL), Intergold Corp. (OTCBB: IGCO), International Broadcasting Corporation (OTCBB: IBCS), InternetStudios, Inc. (OTCBB: ISTO), ITIS Holdings (OTCBB: ITHH), Investco Corp. (OTCBB: IVCO), Lair Holdings (OTC: LAIR), Lifeline BioTechnologies Inc. (OTC: LBTT), Life Energy & Technology (OTCBB: LETH), MBIA (NYSE: MBI); Also, MegaMania Interactive (OTC: MNIA), MetaSource Group, Inc. (OTCBB: MTSR), Midastrade.com (OTC: MIDS), Make Your Move (OTCBB: MKMV), Medinah Minerals (OTC: MDMN), MSM Jewelry Corp. (OTC: MSMC), Nanopierce Technologies, Inc. (OTCBB: NPCT), Nutra Pharmaceutical (OTCBB: NPHC), Nutek (OTCBB: NUTK), Navigator Ventures (OTC: NVGV), Orbit E-Commerce, Inc. (OTCBB: OECI), Pitts & Spitts (OTC: PSPP), Sales OnLine Direct (OTCBB: PAID), Pacel Corp. (OTCBB: PACC), PayStar Corporation (OTC: PYST), Petrogen Corp. (OTCBB: PTGC), Pinnacle Business Management (OTC: PCBM), Premier Development & Investment, Inc. (OTCBB: PDVN), PrimeHoldings.com, Inc. (OTC: PRIM), Phlo Corporation (OTCBB: PHLC), Resourcing Solutions (OTC: RESG), Reed Holdings (OTC: RDHC), Rocky Mountain Energy Corp. (OTCBB: RMECE), RTIN Holdings (OTCBB: RTNHE), Saflink Corp. (NASDAQ: SFLK), Safe Travel Care (OTCBB: SFTVV), Sedona Corp. (OTCBB: SDNA); Also, Sionix Corp. (OTCBB: SINX), Sonoran Energy (OTCBB: SNRN), Starmax Technologies (OTC: SMXIF), Storage Suites America (OTC: SSUA), Suncomm Technologies (OTC: STEH), Sports Resorts International (NASDAQ: SPRI), Technology Logistics (OTC: TLOS), Swiss Medica, Inc. (OTCBB: SWME), Ten Stix, Inc. (OTCBB: TNTI), Tidelands Oil (OTCBB: TIDE), Titan Construction (OTC: TTCS), Trezac Corp. (OTCBB: TRZAV), Universal Express, Inc. (OTCBB: USXP), Valesc Holdings, Inc. (OTCBB: VLSHV), Vega Atlantic (OTCBB: VGAC), Viragen (AMEX: VRA), Viragen International (OTCBB: VGNI), Vista Continental Corporation, (OTCBB: VICC), Viva International (OTCBB: VIVI), Vtex Energy (OTCBB: VXENE) and Wizzard Software (OTCBB: WIZD), WorldTradeShow.com (OTC: WTSW) and Y3K Secure Enterprise Software, Inc. (OTCBB: YTHK). Earlier in 2003, the SEC fined Rhino Advisors, Inc., $1 million for its representation of Amro International in the financing and manipulation of Sedona Corp. Amro, also known as AMRO, was registered in Panama, a secretive offshore haven, but was not named in the SEC settlement. Another 60 public companies may have been manipulated by the fined Rhino Advisors and its indicted principals, or its funding apparatus, Amro. These include: All American Food Group Inc (OTC: AAFGQ), Amanda Co Inc (OTC: AMNA), Antra Holdings (OTC: RECD), Aquis Communications Group Inc (OTCBB: AQUIS), Avanir Pharmaceuticals (AMEX: AVN), Bionutrics Inc (OTC: BNRX), Brilliant Digital Entertainment Inc (AMEX: BDE), Bravo! Foods International Corp. (OTCBB: BRVOE), Butler National Corp (NASDAQ: BUTL), Calypte Biomedical Corp (OTCBB: CYPT), Chemtrak Inc/DE (OTC: CMTR), Clicknsettle Com Inc (OTCBB: CLIK), Corporate Vision Inc (OTC: CVIA), Crown Laboratories Inc/DE (OTC: CLWB), Dental Medical Diagnostic Systems Inc (OTC: DMDS), Detour Media Group Inc (OTC: DTRM), Also, Digital Privacy Inc/DE (OTC: DGPV), Senior Services Inc (OTC: DISS), International Inc (OTC: DYNX), Endovasc Ltd Inc (OTCBB: EVSC), Esynch Corp/CA (OTCBB: ESYN), Focus Enhancements Inc (NASDAQ: FSCE), Frederick Brewing Co (OTC: FRBW), Greystone Digital Technology Inc (OTC: GSTN), Havana Republic Inc/FL (OTCBB: HVNR), Henley Healthcare Inc (OTC: HENL), Hollywood Media Corp (NASDAQ: HOLL), Ibiz Technology Corp (OTCBB: IBZT), Diagnostic Systems Inc/FL (OTCBB: IMDS), Imaging Technologies (OTCBB: IMTO), Integrated Surgical Systems Inc (OTCBB: RDOC), Also, Interferon Sciences Inc (OTC: IFSC), Interiors Inc (OTC: ITRNA), Laminaire Corp (OTC: THMZ), Medisys Technologies Inc (OTC: SCEP), Milestone Scientific Inc/NJ (AMEX: MS), Nevada Manhattan Group Inc (OTC: NVMH), Innovations Inc (OTCBB: NTGE), Systems Group (OTC: OSYM), Pacific Systems Control Technology Inc (OTCBB: PFSY), Professional Transportation Group Ltd Inc (OTC: TRUC), Rnethealth Inc (OTC: RNTT), Also, Sand Technology Inc (NASDAQ: SNDT), Sedona Corp (OTCBB: SDNA), Silverado Foods Inc (OTC: SVFO), Stockgroup Information Systems (OTCBB: SWEB) Surgilight Inc (OTC: SRGL), Tasty Fries Inc (OTCBB: TFRY), Tech Laboratories Inc (OTCBB: TCHL), Teltran International Group Ltd (OTC: TLTG), Titan Motorcycle Co of America Inc (OTC: TMOTQ), Trans Energy Inc (OTCBB: TSRG), Motorcycle Co (OTC: UMCC), Universal Communication Systems Inc (OTCBB: UCSY), Medical Systems Inc (OTC: UMSI), Vianet Technologies Inc (OTC: VNTK),Viragen Inc (AMEX: VRA), Webcatalyst Inc (OTC: WBCL), Worldwide Wireless Networks Inc (OTCBB: WWWNQ), and ZAP (OTCBB: ZAPZ). For up-to-the-minute news, features and links click on www.financialwire.net FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on www.investrend |
| gatorbak, I am an ADVR BULL as you can note by my name. I am not a fan of all the bashers on this board. I have 150,000 shares in this company, accumulating for the last year and hope that what we all dream for will be a drug that comes to market and helps our bretheren. That being said, I want to like you because you are pro advr, but after todays posts and also your posts of the last week, I think you should not post here anymore. You have lost it completely, not that you had anything to offer before, and have become a disgrace to this board and probably to yourself. Why don't you just step aside and allow the market to decide where ADVR will go. I am a true believer and hope that one day, we will be rewarded. Go back to your kitchen, grab a coffee and think about your sickening behaviour. By the way, all you guys like Mind, Rar, Sue, etc. save it. I am gone from this stinking board. GO ADVR!! and I MEAN IT!! |
| Mayo
Clinic Researchers Restore Lost Immunity -- Possible Breakthrough For
AIDS Date: 2004-04-20 ROCHESTER, Minn. -- Mayo Clinic researchers have found a way to revive immunity in mice that have abnormal or deficient immune systems. The discovery may lead to a means of restoring immunity to individuals with immunodeficiency diseases such as AIDS and cancer. Also, because the research involves an existing therapy, application may be possible in the near future. The research team, led by Mayo Clinic immunologists Marilia Cascalho, M.D., Ph.D., and Jeffrey Platt, M.D., report in this month's Journal of Immunology that B cells, the lymphocytes that produce antibodies, help to generate T cells, the lymphocytes that fight viruses and tumors. "Previously, it was thought that B cells and T cells, two components of immunity produced by the lymphatic tissues, develop independently until they eventually came together to fight microbes or to eliminate infected cells in the body," says Dr. Cascalho. "Now we know that the B cells and the immunoglobulin that they produce can help reconstitute immunity by promoting the development of T cells." For immunity to work it is crucial that there are enough T cells and also that the T cells be diverse so they are able to respond to many different threats. B cells help to make the T cells in the body diverse. Immunoglobulin is a specialized protein that acts as an antibody. Diversity of lymphocyte receptors is thought to be the key to immunity. A cell's receptor is the portion that makes it selectively bind with another substance. The more diverse T cell receptors are, the more likely it is T cells of the appropriate specificity will be present to combat today's sophisticated viruses or evasive bacteria. This flexibility and corresponding T cell receptor diversity are absent in patients with immunodeficiency diseases and in some who have cancer or receive cancer treatment. AIDS patients, for example, may have very few T cells and those T cells they have may not be diverse. The report by Dr. Cascalho's group suggests it may be possible to boost T cell numbers and diversity by administration of gamma globulin or B cells. Gamma globulin is a protein portion of blood rich in antibodies that is made from pooled human blood and injected as one form of immunotherapy. "By understanding how the body produces T cell diversity in this way, we believe it may have direct impact on many patients whose immune defenses have been compromised," says Dr. Platt. "There was no way we knew of that this part of the immune system could build itself back up. Now, we think that this is a way." Whether B cells contribute to a diversity of T cells through means other than immunoglobulin isn't known. A Second Possible Approach Dr. Cascalho theorizes that the gamma globulin might also counter autoimmunity. In some cases autoimmune diseases, such as arthritis, arise because the body lacks the diverse T cells needed to control immune responses. She says gamma globulin could promote the production of new T cells which can control the overreacting T cells that attack the body's healthy cells. In this way, clinicians may be able to alter immunity by skewing or redirecting the focus of the body's misdirected immune response. While she says this theory is untested, it could be one more method for controlling autoimmunity. Accelerated Human Trials The next step is to test the current findings in clinical trials. This process may take less time than usual because gamma globulin is approved by the U.S. Food and Drug Administration for other uses. That will allow the researchers to retarget it to verify their discovery in humans. "Because of this availability, we should expect to see some results in a matter of a few years, rather than in a decade or more," says Dr. Cascalho. The researchers want to discover whether all or only part of the immunoglobulin molecule is essential to "jump start" T cell production. If they can identify the critical portion of the molecule, it might be manufactured at less cost than the expensive fully-constituted human immunoglobulin. In addition to the AIDS virus, immune deficiency can be caused by a range of autoimmune diseases, old age, and can be a result of chemotherapy treatments for cancer. Study Details Researchers transferred B cells or gamma globulin from normal mice to those with limited T cell diversity and found that the thymus generated new T cells with increased diversity. However, administration of monoclonal B cells or monoclonal immunoglobulin did not result in production of more diverse T cells, proving that diverse B cells and or immunoglobulin were essential to restore immunity. ### The lead author of the research article, predoctoral student Cristina Joao, worked with Dr. Cascalho, who heads the laboratory, and Dr. Platt, who heads the research program in which the work was carried out. Others involved in the study included Brenda M. Ogle, Ph.D., and Carlota Gay-Rabinstein, M.D. [Cristina João, Brenda M. Ogle, Carlota Gay-Rabinstein, Jeffrey L. Platt, and Marilia Cascalho. (2004). B cell-dependent TCR diversification. J. Immunology 172: 4709 – 4716.] |
| Subject:
Short Selling Scandal could help ADVR Check this out. The MM's might be on the run finally. With any substantial news out of the American Society of Clinical Oncology (ASCO), the short covering could be nice.... StockGate: New Short Selling Scandal Via Berlin Stock Exchange? April 26, 2004. (FinancialWire) Naked short-selling opponents are claiming that "the Berlin Stock Exchange" has listed upwards of 30% of the approximately 100 companies listed by FinancialWire as having been potential targets of naked short-selling in the U.S., apparently without their permission or authorization. U.S. companies supposedly were no longer under the spell of manipulative trading due to changes in regulations some three weeks ago requiring U.S. brokers, such as A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), to refuse orders from Canadian and other brokers without a sure-fire "affirmative determination." Short-selling opponents allege that forged documents may have been used at the Berlin Stock Exchange to list the companies to make them more vulnerable to a continuation of manipulative trading, and that many have had to hire private investigators because the U.S. Securities and Exchange Commission would not investigate or intervene. Financial consultant C. Austin "Bud" Burrell, who has investigated the manipulative abuses and is a close follower of the ongoing controversy, notes that a listing on a foreign exchange qualifies the company's stock for "arbitrage," which Burrell notes is "one of the two specific exemptions from the Short Sale Rule created by the 1993 Administrative Ruling rendered to Broker Dealers, the other being legitimate Market Maker activities." Burrell says that in some instances, "companies have found markets being made in their stock in markets like Berlin, without ever having applied for such a listing. In some cases, the manipulators have actually forged submitted false listing applications supported by the target companies US SEC reports, without their knowledge or consent." Recently, renowned columnist, Jack Anderson, who writes the "Washington Merry-Go-Round," alleged that much of the naked short selling in small cap stocks drains small U.S. companies of their market caps and their small investors of their nest-eggs specifically to funnel money into terrorist hands, a sort of double-whammy against the American capitalist system. "The USA Patriot Act, adopted in October 2001, expanded the scope of U.S. money-laundering rules in order to make it harder for terrorists to move money without attracting attention. It includes beefed-up know-your-customer requirements for some financial institutions, according to some legal experts" said the U.S. financial newspaper. Recently, leading market makers and brokers named in various lawsuits and other actions, including FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion's (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), were given a "reprieve" were forced to comply with new short- selling market regulations imposed by the NASD after the SEC had "sat on" the NASD request to plug material loopholes for almost 2-1/2 years. "The new rules expand the scope of the affirmative determination requirements to include orders received from broker/dealers that are not members of NASD ("non-member broker/dealers"). The new rule is on the web at http://www.nasdr.com/2610_2004.asp#04- 03 The rule itself, while welcomed by small companies and their shareholders in the U.S., nevertheless raised an outcry because the NASD's request to put it into effect had set on a shelf at the SEC since 2001. Recent wrist slaps have involved Falcon Research, Inc., fined $10,000, SG Cowen Securities Corporation, fined $230,000, and Sterne, Agee & Leach, Inc., fined $35,000. Meanwhile, CBS Marketwatch, a venture between Marketwatch (NASDAQ: MKTW) and Viacom's (NYSE: V) CBS unit, has suggested that victims of securities fraud may be able to file for theft claims on tax returns instead of capital losses. The scandal has embroiled hundreds of companies and dozens of brokers and marketmakers, in a web of internaitional intrigue, manipulative short-selling and cross-border accusations and denials. Comments on Regulation SHO ended January 5, and may be viewed at http://www.sec.gov/rules/proposed/s72303.shtml . Some 122 companies, including 13 brokers, such as FleetBoston (NYSE: FBF), Goldman, Sachs & Co. (NYSE: GS), H. Myerson & Co., Inc. (NASDAQ: MHMY), Olde / H&R Block (NYSE: HRB), Charles Schwab (NYSE: SCH), Toronto-Dominion's (NYSE: TD), TD Waterhouse Group and vFinance, Inc. (OTCBB: VFIN). A.G. Edwards, Inc. (NYSE: AGE), Ameritrade Holding Corp. (NASDAQ: AMTD), Deutsche Bank AG (NYSE: DB), and ETrade Group, Inc. (NYSE: ET), have been embroiled for over a year in a raging controversy The remaining 109 companies among the 122 named to date have issued press releases or been named in the media as having been victimized, or as taking various actions, either alone or in concert with other companies, to oppose manipulative trading in the form of illegal naked short selling. The actions have ranged from lawsuits to withdrawals and threatened withdrawals from the electronic trading system managed by the Depository Trust & Clearing Corp., to withdrawals from toxic financings, to the issuance of dividends or name changes designed to squeeze manipulators, to joining associations or networks or to contacting regulatory authorities to provide documentation of abuses or otherwise complain. The complete list of those 108 companies include ***Advanced Viral Research Corp.*** (OTCBB: ADVR), AdZone Research, Inc. (OTCBB: ADZR), Amazon Natural Treasures (OTC: ANTD), America's Senior Financial Services (OTCBB: AMSE), American Ammunition, Inc. (OTCBB: AAMI), AngelCiti Entertainment (OTCBB: AGLC), ATSI Communications, Inc. (OTC: ATSC), Federal Agricultural Mortgage / Farmer Mac (NYSE: AGM) Allied Capital (NYSE: ALD), American Motorcycle (OTC: AMCYV), American International Industries (OTCBB: AMIN), Ameri-Dream (OTC: AMDR), Adirondack Pure Springs Mt. Water Co. (OTCBB: APSW), ATSI Communications, Inc. (OTC: ATSC) Bluebook International (OTCBB: BBIC), Blue Industries (OTCBB: BLIIV), Bentley Communications (OTCBB: BTLY), BIFS Technologies Corporation (OTCBB: BIFT), Biocurex (OTCBB: BOCX). Broadleaf Capital Partners, Inc. (OTCBB: BDLF), Chattem, Inc. (NASDAQ: CHTT), Critical Home Care (OTCBB: CCLH), Composite Holdings (OTC: COHIA), CyberDigital, Inc. (OTCBB: CYBD). Diamond International Group (OTCBB: DMND), Dobson Communications Corp. (NASDAQ: DCEL), Eagle Tech Communications (OTC: EATC), Edgetech Services (OTCBB: EDGH); Also, Endovasc Ltd. (OTCBB: EVSC), Enviro-Energy Corporation (OTCBB: ENGY), Environmental Products & Technologies (OTC: EPTC), Environmental Solutions Worldwide, Inc. (OTCBB: ESWW), EPIXTAR Corp. (OTCBB: EPXR), eResearchTechnologies, Inc. (NASDAQ: ERES), Flight Safety Technologies (OTCBB: FLST), Freddie Mac (NYSE: FRE), FreeStar Technologies (OTCBB: FSRCE), Front Porch Digital, Inc. (OTCBB: FPDI), Geotec Thermal Generators, Inc. (OTCBB: GETC), Genesis Intermedia (OTC: GENI), GeneMax Corp. (OTCBB: GMXX), Global Explorations Inc (OTC: GXXL), Global Path (OTCBB: GBPI), GloTech Industries, Inc. (OTCBB: GTHI), Green Dolphin Systems (OTCBB: GLDS), Group Management (OTCBB: GPMT), Hop-On (OTC: HPON), H-Quotient, Inc., (OTCBB: HQNT), Hyperdynamics Corp. (OTCBB: HYPD), International Biochem (OTCBB: IBCL), Intergold Corp. (OTCBB: IGCO), International Broadcasting Corporation (OTCBB: IBCS), InternetStudios, Inc. (OTCBB: ISTO), ITIS Holdings (OTCBB: ITHH), Investco Corp. (OTCBB: IVCO), Lair Holdings (OTC: LAIR), Lifeline BioTechnologies Inc. (OTC: LBTT), Life Energy & Technology (OTCBB: LETH), MBIA (NYSE: MBI); Also, MegaMania Interactive (OTC: MNIA), MetaSource Group, Inc. (OTCBB: MTSR), Midastrade.com (OTC: MIDS), Make Your Move (OTCBB: MKMV), Medinah Minerals (OTC: MDMN), MSM Jewelry Corp. (OTC: MSMC), Nanopierce Technologies, Inc. (OTCBB: NPCT), Nutra Pharmaceutical (OTCBB: NPHC), Nutek (OTCBB: NUTK), Navigator Ventures (OTC: NVGV), Orbit E-Commerce, Inc. (OTCBB: OECI), Pitts & Spitts (OTC: PSPP), Sales OnLine Direct (OTCBB: PAID), Pacel Corp. (OTCBB: PACC), PayStar Corporation (OTC: PYST), Petrogen Corp. (OTCBB: PTGC), Pinnacle Business Management (OTC: PCBM), Premier Development & Investment, Inc. (OTCBB: PDVN), PrimeHoldings.com, Inc. (OTC: PRIM), Phlo Corporation (OTCBB: PHLC), Resourcing Solutions (OTC: RESG), Reed Holdings (OTC: RDHC), Rocky Mountain Energy Corp. (OTCBB: RMECE), RTIN Holdings (OTCBB: RTNHE), Saflink Corp. (NASDAQ: SFLK), Safe Travel Care (OTCBB: SFTVV), Sedona Corp. (OTCBB: SDNA); Also, Sionix Corp. (OTCBB: SINX), Sonoran Energy (OTCBB: SNRN), Starmax Technologies (OTC: SMXIF), Storage Suites America (OTC: SSUA), Suncomm Technologies (OTC: STEH), Sports Resorts International (NASDAQ: SPRI), Technology Logistics (OTC: TLOS), Swiss Medica, Inc. (OTCBB: SWME), Ten Stix, Inc. (OTCBB: TNTI), Tidelands Oil (OTCBB: TIDE), Titan Construction (OTC: TTCS), Trezac Corp. (OTCBB: TRZAV), Universal Express, Inc. (OTCBB: USXP), Valesc Holdings, Inc. (OTCBB: VLSHV), Vega Atlantic (OTCBB: VGAC), Viragen (AMEX: VRA), Viragen International (OTCBB: VGNI), Vista Continental Corporation, (OTCBB: VICC), Viva International (OTCBB: VIVI), Vtex Energy (OTCBB: VXENE) and Wizzard Software (OTCBB: WIZD), WorldTradeShow.com (OTC: WTSW) and Y3K Secure Enterprise Software, Inc. (OTCBB: YTHK). Earlier in 2003, the SEC fined Rhino Advisors, Inc., $1 million for its representation of Amro International in the financing and manipulation of Sedona Corp. Amro, also known as AMRO, was registered in Panama, a secretive offshore haven, but was not named in the SEC settlement. Another 60 public companies may have been manipulated by the fined Rhino Advisors and its indicted principals, or its funding apparatus, Amro. These include: All American Food Group Inc (OTC: AAFGQ), Amanda Co Inc (OTC: AMNA), Antra Holdings (OTC: RECD), Aquis Communications Group Inc (OTCBB: AQUIS), Avanir Pharmaceuticals (AMEX: AVN), Bionutrics Inc (OTC: BNRX), Brilliant Digital Entertainment Inc (AMEX: BDE), Bravo! Foods International Corp. (OTCBB: BRVOE), Butler National Corp (NASDAQ: BUTL), Calypte Biomedical Corp (OTCBB: CYPT), Chemtrak Inc/DE (OTC: CMTR), Clicknsettle Com Inc (OTCBB: CLIK), Corporate Vision Inc (OTC: CVIA), Crown Laboratories Inc/DE (OTC: CLWB), Dental Medical Diagnostic Systems Inc (OTC: DMDS), Detour Media Group Inc (OTC: DTRM), Also, Digital Privacy Inc/DE (OTC: DGPV), Senior Services Inc (OTC: DISS), International Inc (OTC: DYNX), Endovasc Ltd Inc (OTCBB: EVSC), Esynch Corp/CA (OTCBB: ESYN), Focus Enhancements Inc (NASDAQ: FSCE), Frederick Brewing Co (OTC: FRBW), Greystone Digital Technology Inc (OTC: GSTN), Havana Republic Inc/FL (OTCBB: HVNR), Henley Healthcare Inc (OTC: HENL), Hollywood Media Corp (NASDAQ: HOLL), Ibiz Technology Corp (OTCBB: IBZT), Diagnostic Systems Inc/FL (OTCBB: IMDS), Imaging Technologies (OTCBB: IMTO), Integrated Surgical Systems Inc (OTCBB: RDOC), Also, Interferon Sciences Inc (OTC: IFSC), Interiors Inc (OTC: ITRNA), Laminaire Corp (OTC: THMZ), Medisys Technologies Inc (OTC: SCEP), Milestone Scientific Inc/NJ (AMEX: MS), Nevada Manhattan Group Inc (OTC: NVMH), Innovations Inc (OTCBB: NTGE), Systems Group (OTC: OSYM), Pacific Systems Control Technology Inc (OTCBB: PFSY), Professional Transportation Group Ltd Inc (OTC: TRUC), Rnethealth Inc (OTC: RNTT), Also, Sand Technology Inc (NASDAQ: SNDT), Sedona Corp (OTCBB: SDNA), Silverado Foods Inc (OTC: SVFO), Stockgroup Information Systems (OTCBB: SWEB) Surgilight Inc (OTC: SRGL), Tasty Fries Inc (OTCBB: TFRY), Tech Laboratories Inc (OTCBB: TCHL), Teltran International Group Ltd (OTC: TLTG), Titan Motorcycle Co of America Inc (OTC: TMOTQ), Trans Energy Inc (OTCBB: TSRG), Motorcycle Co (OTC: UMCC), Universal Communication Systems Inc (OTCBB: UCSY), Medical Systems Inc (OTC: UMSI), Vianet Technologies Inc (OTC: VNTK),Viragen Inc (AMEX: VRA), Webcatalyst Inc (OTC: WBCL), Worldwide Wireless Networks Inc (OTCBB: WWWNQ), and ZAP (OTCBB: ZAPZ). For up-to-the-minute news, features and links click on http://www.financialwire.net |
| Bullish
on Biotech Source: The Centient Investor 04/09/2004 “You may wonder, is this the 2000 bubble all over again ? Or is this truly a sustainable entry point to the market . . . ? Major events have already happened in biotechnology that will profoundly influence society at large - a revolution not unlike the Copernican revolution 500 years ago. . . . The human genome has been sequenced - a heroic effort spanning nearly two decades, but the final prize is in. Now the technology exists to do it for every individual on the planet. The $1,000 genome initiative is in full swing. And knowing an individual's genetic blueprint will affect everything we do. From insurance to settling down and raising a family to retirement planning. But it won't stop there. We can and will sequence the genomes of plants and animals. And knowledge is power - once we know the genome we can change it. Already, genetically modified foods have raised health concerns and entered the international policy debate. But putting a gene in a plant to increase yield is nothing new - breeders have done this the old fashioned way for over 5,000 years. We are looking at changing plants and animals (and some would say people) to suit our needs. We are looking at stem cells, cloning for spares, designer babies, nutraceuticals, you name it. Bioengineering is here to stay and the world will not be the same 10 years from now. Take a look at the demographics. All over the Western world, the population is aging. The baby boomers are entering their "silver" years. With aging comes killer diseases like cancer, diabetes, Alzheimer's and cardiovascular disease. But aging in and of itself is enough to scare most people. And this is not a generation that will just sit back and grow old. This is a generation of activist health consumers who are determined to fight back. As Woody Allen put: I want to achieve immortality by not dying. And just how much are these activists willing to pay to stay young ? At a recent survey of older executives, pollsters found that many were very willing to part with up to 95% of their fortunes for the chance to be 40 again. When asked why, one executive said: Well, if I was younger, with my Rolodex, I could make it all back within two years. But is biotech delivering on its promise? Are companies and their investors going to make money? Recent surveys found that 75% of the new drugs (the new molecular entities not the reformulated and enhanced aspirins of the world) are developed by small companies - not big pharma. In fact, big pharma are creating new drugs at a rate of only 0.6 new drugs per company per year - a snails pace. So big pharma is acquiring promising companies left and right to fill their pipelines providing the smaller biotechs with an simpler and quicker path to financial success. We are bullish on biotech. Sure, biotech investing is not for the faint of heart. Significant hurdles exist and getting a biotech company off the ground and a drug to market is not easy. Money for new ideas is difficult to come by. The IP situation is treacherous and in serious need of overhaul. The regulatory environment is stifling. Big pharma is in deep trouble (although that maybe not apparent yet). General acceptance cannot be taken for granted. And a news story can destroy a blockbuster in a day and company in a week. But the fundamentals are right. The demographics are there. And the sheer size of accumulated knowledge is driving entrepreneurs to launch more biotechs than ever before possible. Now it’s just a matter of picking the winners! Onwards and upwards!” (April 9, 2004) |
| My
original post (#148738) on this current issue from this past Saturday
following the run-up on Friday:: --------------------------------- "So...I'm curious. If ADVR had ANYTHING to do with the pumping newsletter (contacts, phone calls, or/and emails) that was sent to millions of potential penny investors Friday (and really not mentioning ANYTHING we don't already know or isn't posted on ADVR's Web page), are they legally culpable in terms of aiding and abetting the manipulation of prices by behind-the-scenes-communications using a spamming newsletter?? And add to that, did any cash change hands from ADVR and the newsletter/email? Did the newsletter owners or employees buy shares in anticipation of the spam so that they lined their own pockets?? A long time ago, ADVR was involved in a case that is similar to this. Curious minds are interested. If in fact the ENTIRE debacle is based on a simple newsletter publicizing the ADVR and no news at all, is this a fair way for traders who know this is going out beforehand? Is there any tie-in with the Dicke financing? If the news is JUST the pumping newsletter, all traders better watch their back when the end-point is reached the drop will be precipitous and the shares traded will be huge!! Good luck all!! |
| OUROS...you
just answered my question. Thanks. A chill just went up my spine. GLTA. (Voluntary Disclosure: Position- No Position) |
| Hi
All,Just received this email.....Aven1....READ LAST PARAGRAPH!! To: ADVR-AdvancedViralResearch@yahoogroups.com From: "cherkassypocket" Add to Address Book Date: Tue, 27 Apr 2004 02:35:48 -0000 Subject: [Advanced Viral is Reticulose] Hawkins will be presenting this weekend in FL Current shareholders and potential new investors are invited. Could be interesting next Monday. ASCO abstracts will be available to ASCO members by May 24. June 5--ADVR is presenting at a Small Cap Equities Conference in NY. Boston presentation is coming up also. And keep an eye on The Jerusalem Post...article is coming on the cachexia trials at Kaplan Medical Center. The time may well be nigh. (Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy) |